A major emphasis of the Vermont Pulmonary SCOR research has centered on cellular pathogenic mechanisms in lung injury and fibrosis. This has required the establishment and/or maintenance of a variety of in vitro cell cultures of human and animal lung origin. Most SCOR projects will continue to be involved with studies of normal lung cell biology as well as their response to etiologic agents of pulmonary pathology. Included are studies of mesenchymal cell proliferation, collagen metabolism, differentiated function, and cellular interactions. The goal of this Core is to establish a Cell Culture Facility which will provide cultured lung cells for SCOR research. Established cell lines such as embryonic human diploid lung fibroblasts, IMR- 90, mouse 3T3 cells will be maintained for use. Additionally, several lines of human lung fibroblasts from biopsy specimens derived from lung tissue of fibrosis patients, normal human lung tissue and lung tissue of rats have been isolated and maintained by Vermont SCOR investigators and are cryopreserved in liquid nitrogen. Several of these will continue to be studied. New cell cultures will be isolated for individual research projects, such as Type II epithelial cells for studies of cytoskeletal proteins as well as other fibroblast lines as required for appropriate studies. The establishment of a Core Cell Culture Facility will enable us to meet the increasing needs of SCOR investigators for critical supplies of cell cultures established and maintained under standardized conditions that are essential for the types of multisdisciplinary studies outlined in this proposal.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
2P50HL014212-16
Application #
3943195
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Quinlan, T R; Marsh, J P; Janssen, Y M et al. (1994) Dose-responsive increases in pulmonary fibrosis after inhalation of asbestos. Am J Respir Crit Care Med 150:200-6
Roggli, V L; Coin, P G; MacIntyre, N R et al. (1994) Asbestos content of bronchoalveolar lavage fluid. A comparison of light and scanning electron microscopic analysis. Acta Cytol 38:502-10
Quinlan, T; Spivack, S; Mossman, B T (1994) Regulation of antioxidant enzymes in lung after oxidant injury. Environ Health Perspect 102 Suppl 2:79-87
Mossman, B T; Janssen, Y M; Marsh, J P et al. (1991) Development and characterization of a rapid-onset rodent inhalation model of asbestosis for disease prevention. Toxicol Pathol 19:412-8
Mossman, B T; Marsh, J P; Sesko, A et al. (1990) Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis 141:1266-71
Scott, S M; Buenaflor, G G; Orth, D N (1989) Immunoreactive human epidermal growth factor concentrations in amniotic fluid, umbilical artery and vein serum, and placenta in full-term and preterm infants. Biol Neonate 56:246-51
Ramage Jr, J E; Roggli, V L; Bell, D Y et al. (1988) Interstitial lung disease and domestic wood burning. Am Rev Respir Dis 137:1229-32
Fisher, G L; Mossman, B T; McFarland, A R et al. (1987) A possible mechanism of chrysotile asbestos toxicity. Drug Chem Toxicol 10:109-31
Mossman, B T; Gilbert, R; Doherty, J et al. (1986) Cellular and molecular mechanisms of asbestosis. Chest 89:160S-161S
Bell, D Y; Johnson, S M; Piantadosi, C A (1986) Elevated serum immunoglobulin G levels and bronchoalveolar lymphocytosis as predictors of clinical course in pulmonary sarcoidosis. Ann N Y Acad Sci 465:672-7

Showing the most recent 10 out of 11 publications